EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome
George C Drosos, Daisy Vedder, Eline Houben, Laura Boekel, Fabiola Atzeni, Sara Badreh, Dimitrios T. Boumpas, Nina Brodin, Ian N Bruce, Miguel Á. González‐Gay, Søren Jacobsen, György Kerekes, Francesca Marchiori, Chetan Mukhtyar, Manuel Ramos‐Casals, Naveed Sattar, Karen Schreiber, Savino Sciascia, Elisabet Svenungsson, Zoltán Szekanecz, Anne‐Kathrin Tausche, Alan Tyndall, Vokko van Halm, Alexandre E. Voskuyl, Gary J. Macfarlane, Michael M. Ward, Michael T. Nurmohamed, Maria G. Tektonidou
Topics & Concepts
MedicineAntiphospholipid syndromeHydroxychloroquineLupus erythematosusSystemic lupusIntensive care medicineImmunologyDermatologyPhysical therapyThrombosisInternal medicineDiseaseAntibodyInfectious disease (medical specialty)Coronavirus disease 2019 (COVID-19)Systemic Lupus Erythematosus ResearchSystemic Sclerosis and Related DiseasesRheumatoid Arthritis Research and Therapies